The Venture Codex Logo

The Venture Codex

Overview

Pediatric health care and research center delivering specialized treatments

Founded

1894

Deals ยท 12mo

1

Stage focus

Series A
Series C

Geographic focus

United States

Sector focus

Children
Health Care
Medical

Investment portfolio

2rounds
NAMEDATESIZE
Angel Eye Health
Dec 2025Participated
$9 MSeries C
Clarametyx Biosciences
Jan 2024Participated
$33 MSeries A
Angel Eye Health
Dec 2025Participated
$9 MSeries C
Clarametyx Biosciences
Jan 2024Participated
$33 MSeries A
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Nationwide Children: 2 funding rounds are recorded in the selected participation categories.All available history.
Nationwide Children: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series C+01

Monthly Deal Activity

Nationwide Children: 2 deals are recorded across 34 months.All available history.
Nationwide Children: 2 deals are recorded across 34 months. All available history
MonthDeals
Jan '241
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Nationwide Children: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Nationwide Children: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2
Networks, Cloud & Communication1
Enterprise Software1

Deal Size Distribution

Nationwide Children: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Nationwide Children: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M0
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Nationwide Children: United States has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Nationwide Children: United States has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
United States2
Nationwide Children: 7 co-investors are shown, with 1776 sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Nationwide Children: 7 co-investors are shown, with 1776 sharing 1 recorded deals. All available history
Co-investorShared deals
17761
C Bio Investors1
Cystic Fibrosis Foundation1
JobsOhio Growth Capital1
Mountain Group Partners1
Ohio Innovation Fund1
Rev1 Ventures1

Investment Strategy

Nationwide Children: Led accounts for 0% and participating for 100% of round participation.All available history.
Nationwide Children: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating2100%
Nationwide Children: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Nationwide Children: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Catherine Cottrell

Director, Institute for Genomic Medicine Clinical Laboratory

Chet Kaczor

Vice President of Operations

Jerry Mendell

Director, Center for Gene Therapy

Kenneth Washburn

Director of Abdominal Transplantation

Malcolm Sutherland-Foggio

Clinical Research Coordinator

Mike Fitzpatrick

Board Member

Timothy P. Cripe

Professor and Chief of Hematology,Oncology,BMT